This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Mammography World Markets

Figure 6.23: Participation in Breast Cancer Screening by Age in Japan, 2007 108

Figure 6.24: Participation in BreastScreen Australia by Women Aged 50-69, 2000-2010 110

Figure 6.25: MBS-Funded Mammography Services by Age Group in Australian Women, 2011 111

Figure 7.1: Global Market for Mammography Systems, 2011-2018 113

Figure 7.2: Global Market for FFDM Mammography Equipment, 2011-2018 114

Figure 7.3: Global Market Leaders in Mammography Equipment Market, 2011 115

Figure 7.4: U.S. Market for Full-Field Digital Mammography Market, 2011-2018 116

Figure 7.5: U.S. Mammography Units and Facilities, 2000-2011 117

Figure 7.6: Growth in Number of FFDM Units and Facilities in the U.S., 2004-2010 118

Figure 7.7: Rest of the World Market for Mammography Equipment, 2011-2018 119

Figure 7.8: European Market for Mammography System, 2011-2018 120

Figure A2.1: Tumor Sizes 140

Figure A5.1: Improvement in Cancer Detection 154

Figure A5.2: Increased Breast Cancer Detection Using Tomosynthesis 155

Figure A5.3: Reduced Recall Rates 155

Figure A5.4: Added Value for Calcifications 156

Figure A5.5: Value of Tomosynthesis in Fatty Breasts 157

Figure A5.6: Greater Perception of Extent of Disease Using Tomosynthesis 158

Figure A5.7: Two-View Tomosynthesis Optimizes Chance for Cancer Detection 158

Figure A5.8: Dose Levels of 2D and Tomo Exams Compared to Natural Background Radiation 159

Figure A6.1: Breast Cancer in the U.S. by Race and Stage at Diagnosis 162

Figure A6.2: Female Breast Cancer Treatment Patterns by Stage 163

Figure A6.3: Five-Year Survival Rates for Breast Cancer Patients by Race and Stage at Diagnosis 164

Figure A6.4: Distribution of Colon and Rectum Cancer by Race and Stage at Diagnosis 167

Figure A6.5: Colon Cancer Treatment Patterns by Stage 167

Figure A6.6: Rectal Cancer Treatment Patterns by Stage 168

Figure A6.7: Five-Year Survival Rates for Colon and Rectal Cancer Patients by Race and Stage at Diagnosis 169

Figure A6.8: Distribution (%) of Non-Hodgkin Lymphoma Patients by Race and Stage at Diagnosis 170

10 of 14

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.21 -0.44%
FB $117.80 -0.22%
GOOG $701.26 0.80%
TSLA $211.53 -4.96%
YHOO $36.94 2.61%


Chart of I:DJI
DOW 17,660.71 +9.45 0.05%
S&P 500 2,050.63 -0.49 -0.02%
NASDAQ 4,717.0940 -8.5450 -0.18%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs